Trading status
Status
de
Prices realtime
Indizes
UC DAX
UC MDAX
UC TECDAX
UC DJI
UC ESTOXX
UC NASQAD 100
Shares
ETFs & FUNDS
Bonds
Crypto
Screen markets
Stock screener
Certifcate Screener
ETF Screener
Fund Screener
Bond screener
Trading ideas
risk indices
risk indices
EU Intraday
EU Long Term
US Intraday
US Longterm
New on gettex
New listings stocks
New listings bonds
New intraday certificates
Blog
Newsletter
Watchlist
Support
Trading
Trading Calendar
Extended trading hours
Listing on demand
Announcements
Quality Reports
Delayed Data
Regulations
Become a Trade Participant
Cancellations
About Gettex
FAQs
Press
Partners
Committees
Career
Service & Contact
Why gettex
Experts from BNP Paribas explain.
News
2025/12/04 08:30
EQS-News: Evotec-partner Bayer starts Phase 2 study for treatment of patients with Alport syndrome
2025/11/12 07:30
EQS-News: Evotec receives milestone payment from Bristol Myers Squibb following IND acceptance in strategic protein degradation partnership
2025/10/29 09:45
EQS-News: Evotec SE to announce results for the first nine months 2025 on 05 November 2025
2025/10/27 07:30
EQS-News: Evotec announces progress in preclinical neuroscience partnership with Bristol Myers Squibb
2025/08/13 07:00
EQS-News: Evotec SE reports H1 2025 results: Strong progress on strategy execution
2025/08/06 09:52
EQS-News: Evotec SE to announce first half-year results 2025 on 13 August 2025
2025/07/30 07:16
EQS-News: Evotec and Sandoz evolve their strategic partnership and agree on potential sale of Just – Evotec Biologics Toulouse site
2025/07/30 07:14
EQS-Adhoc: Evotec SE and Sandoz AG planning potential sale of Just – Evotec Biologics Toulouse site